Chavez, Anita P.

HRN: 14-46-22  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/11/2022
CEFTRIAXONE 1G (VIAL)
11/11/2022
11/17/2022
IVT
2 G
Once A Day
Infectious Diarrhea
Waiting Final Action 
11/11/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/11/2022
11/17/2022
IVT
500 Mg
Q8
Giardiasis
Waiting Final Action 
11/14/2022
METRONIDAZOLE 500MG (TAB)
11/14/2022
11/21/2022
PO
500mg
Q8
Intestinal Ameobiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: